The medical laser systems market in the Middle East & Africa is expected to grow from US$ 108.05 million in 2021 to US$ 248.87 million by 2028; it is estimated to grow at a CAGR of 12.7% from 2021 to 2028.
After cataracts, corneal diseases are the second-leading cause of blindness. The epidemiology of corneal blindness is complex, including various infectious and inflammatory eye diseases, resulting in corneal scarring and, ultimately, functional blindness. In addition, the prevalence of corneal diseases varies with countries and their populations. Laser vision correction is one of the most common surgical procedures. The primary reasons for the increasing preference of patients for laser vision correction are the continued improvements in the visual results achieved and the constant reduction in the incidence of postoperative complications. Advances in flap formation technology, such as the use of the femtosecond laser, have resulted in an improved quality of vision and a lower incidence of flap complications and postoperative dry eye disease (DED). Apart from this, advances in laser ablation profiles have resulted in a better quality of vision, including better night vision. Thus, the rising prevalence of eye diseases highly demands medical lasers.
Alcon Inc; Artivion, Inc.; Bausch Health Companies Inc.; BIOLASE, Inc.; Boston Scientific Corporation; Candela Medical; Iridex Corporation; Koninklijke Philips N.V.; and Lumenis Be Ltd. are among the leading companies operating in the Middle East & Africa medical laser systems market.
After cataracts, corneal diseases are the second-leading cause of blindness. The epidemiology of corneal blindness is complex, including various infectious and inflammatory eye diseases, resulting in corneal scarring and, ultimately, functional blindness. In addition, the prevalence of corneal diseases varies with countries and their populations. Laser vision correction is one of the most common surgical procedures. The primary reasons for the increasing preference of patients for laser vision correction are the continued improvements in the visual results achieved and the constant reduction in the incidence of postoperative complications. Advances in flap formation technology, such as the use of the femtosecond laser, have resulted in an improved quality of vision and a lower incidence of flap complications and postoperative dry eye disease (DED). Apart from this, advances in laser ablation profiles have resulted in a better quality of vision, including better night vision. Thus, the rising prevalence of eye diseases highly demands medical lasers.
Middle East & Africa Medical Laser Systems Market Segmentation
The Middle East & Africa medical laser systems market is segmented based on product type, application, end user, and country. Based on product type, the market has been segmented into diode lasers, solid state lasers, gas lasers, fiber lasers and dye lasers. In 2020, the solid state lasers segment held the largest share of the market. The solid state lasers segment is subsegmented into holmium yttrium aluminum garnet (Ho:Yag) lasers, erbium yttrium aluminum garnet (Er:Yag) lasers, neodynium yttrium aluminum garnet (Nd:Yag) lasers, thulium:yttrium-aluminum-garnet laser (Tm:YAG), potassium titanyl phosphate (KTP), alexandrite lasers, and ruby lasers. In 2020, the erbium yttrium aluminum garnet (Er:Yag) lasers segment held the largest share. Based on gas lasers, the market is subsegmented into CO2 laser, argon laser, krypton laser, metal vapor laser, helium neon laser, and excimer laser. In 2020, the CO2 laser segment held the largest share. Based on fiber lasers, the market is subsegmented into thulium fiber lasers, erbium fiber lasers, and ytterbium fiber lasers. In 2020, the thulium fiber lasers segment held the largest share. Based on application, the market has been segmented into dermatology, ophthalmology, gynecology, dentistry, cardiology, urology, and others. In 2020, the dermatology segment held the largest market share. Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgery centers, and others. In 2020, the specialty clinics segment held the largest market share. Similarly, based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia contributed a substantial share in 2020.Alcon Inc; Artivion, Inc.; Bausch Health Companies Inc.; BIOLASE, Inc.; Boston Scientific Corporation; Candela Medical; Iridex Corporation; Koninklijke Philips N.V.; and Lumenis Be Ltd. are among the leading companies operating in the Middle East & Africa medical laser systems market.
Table of Contents
1. Introduction
3. Research Methodology
4. MEA Medical Lasers Systems Market - Market Landscape
5. MEA Medical Laser Systems Market - Key Market Dynamics
6. Medical Laser Systems Market- MEA Analysis
7. MEA Medical Lasers Market- By Product Type
8. MEA Medical Laser Systems Market- By Application
9. MEA Medical Laser Systems Market - By End User
10. MEA Medical Laser Systems Market- Country Analysis
11. MEA Medical Laser System Market-Industry Landscape
12. Company Profiles
13. Appendix
List of Figures
List of Tables
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alcon Inc
- Artivion, Inc.
- Bausch Health Companies Inc.
- BIOLASE, Inc.
- Boston Scientific Corporation
- Candela Medical
- Iridex Corporation
- Koninklijke Philips N.V.
- Lumenis Be Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 191 |
| Published | July 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 108.05 Million |
| Forecasted Market Value ( USD | $ 248.87 Million |
| Compound Annual Growth Rate | 12.7% |
| Regions Covered | Africa, Middle East |
